Literature DB >> 19834059

Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway.

Holger Hägele1, Ramanjaneyulu Allam, Rahul D Pawar, Christoph A Reichel, Fritz Krombach, Hans-Joachim Anders.   

Abstract

Viral DNA induces potent antiviral immunity by activating dendritic cells; however, the mechanism governing viral DNA-mediated triggering or aggravation of glomerulonephritis is unknown. Glomerular endothelial cells (GEnCs) do not express toll-like receptor (TLR)9, the only DNA-specific TLR. We therefore hypothesized that DNA could activate GEnCs via the recently discovered TLR-independent viral DNA recognition pathway. Indeed, double-stranded non-CpG (B-) DNA activated GEnCs to produce interleukin-6, CCL5/RANTES, CCL2/MCP-1, CXCL10/IP10, interferon (IFN)-alpha, and IFN-beta when cationic lipids facilitated intracellular DNA uptake. This cytokine production was inhibited by chlorpromazine, suggesting that clathrin-dependent endocytosis is required for B-DNA entry. However, chloroquine and MyD88 inhibition did not affect GEnC activation, suggesting TLR-independent DNA recognition. In addition, IFN-beta activated cytokine and chemokine mRNA expression, although only CXCL10/IP10 was induced at the protein level, and type I IFN did not activate GEnC in an autocrine-paracrine auto-activation loop. B-DNA complexes induced intercellular adhesion molecule-1 expression at the GEnC surface and increased intercellular adhesion molecule-1-dependent leukocyte adhesion and microvascular extravasation in vivo. Furthermore, B-DNA complexes increased albumin permeability of GEnC monolayers in culture or microvascular dextran leakage in vivo. In addition, B-DNA complexes impaired GEnC proliferation. Thus, complexed B-DNA activates GEnC to produce cytokines, chemokines, and type I IFNs, increases leukocyte adhesion and microvascular permeability, and reduces GEnC proliferation via a MyD88-independent cytosolic DNA recognition pathway. This innate antiviral response program suggests a novel pathomechanism regulating DNA virus-mediated induction or aggravation of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834059      PMCID: PMC2774054          DOI: 10.2353/ajpath.2009.090182

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

Review 1.  Evolving functions of endothelial cells in inflammation.

Authors:  Jordan S Pober; William C Sessa
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

2.  The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response.

Authors:  Daniel A Muruve; Virginie Pétrilli; Anne K Zaiss; Lindsay R White; Sharon A Clark; P Joel Ross; Robin J Parks; Jurg Tschopp
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

Review 3.  The IRF family transcription factors in immunity and oncogenesis.

Authors:  Tomohiko Tamura; Hideyuki Yanai; David Savitsky; Tadatsugu Taniguchi
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 4.  Properties of the glomerular barrier and mechanisms of proteinuria.

Authors:  Börje Haraldsson; Jenny Nyström; William M Deen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

5.  Gelatinases mediate neutrophil recruitment in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling.

Authors:  Christoph A Reichel; Markus Rehberg; Peter Bihari; Christian M Moser; Stefan Linder; Andrej Khandoga; Fritz Krombach
Journal:  J Leukoc Biol       Date:  2008-01-03       Impact factor: 4.962

6.  Small self-RNA generated by RNase L amplifies antiviral innate immunity.

Authors:  Krishnamurthy Malathi; Beihua Dong; Michael Gale; Robert H Silverman
Journal:  Nature       Date:  2007-07-25       Impact factor: 49.962

7.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.

Authors:  Akinori Takaoka; Zhichao Wang; Myoung Kwon Choi; Hideyuki Yanai; Hideo Negishi; Tatsuma Ban; Yan Lu; Makoto Miyagishi; Tatsuhiko Kodama; Kenya Honda; Yusuke Ohba; Tadatsugu Taniguchi
Journal:  Nature       Date:  2007-07-08       Impact factor: 49.962

8.  Interferon-beta reduces proteinuria in experimental glomerulonephritis.

Authors:  Simon C Satchell; Olena Buchatska; Sarah B Khan; Gurjeet Bhangal; Candida H Tasman; Moin A Saleem; Darren P Baker; Roy R Lobb; Jennifer Smith; H Terence Cook; Peter W Mathieson; Charles D Pusey
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

Review 9.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

Review 10.  Interferons at age 50: past, current and future impact on biomedicine.

Authors:  Ernest C Borden; Ganes C Sen; Gilles Uze; Robert H Silverman; Richard M Ransohoff; Graham R Foster; George R Stark
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

View more
  24 in total

1.  Interferon-α and interleukin-12 are induced, respectively, by double-stranded DNA and single-stranded RNA in human myeloid dendritic cells.

Authors:  Yuichi Katashiba; Rie Miyamoto; Akira Hyo; Keiko Shimamoto; Naoko Murakami; Makoto Ogata; Ryuichi Amakawa; Muneo Inaba; Shosaku Nomura; Shirou Fukuhara; Tomoki Ito
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

Review 2.  Necroinflammation in Kidney Disease.

Authors:  Shrikant R Mulay; Andreas Linkermann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

Review 3.  Structural modification of DNA--a therapeutic option in SLE?

Authors:  Steffen Frese; Betty Diamond
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

Review 4.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

Review 5.  Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.

Authors:  Beatriz Suárez-Álvarez; Helen Liapis; Hans-Joachim Anders
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

6.  Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study.

Authors:  V Foschi; D Bortolotti; A F Doyle; V Stratigou; L Stephens; P Trivedi; R Rinaldi; M Padovan; A Bortoluzzi; L Lightstone; T D Cairns; M Botto; T H Cook; R Rizzo; M Govoni; M C Pickering
Journal:  Lupus       Date:  2019-07-10       Impact factor: 2.911

Review 7.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

8.  Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes.

Authors:  Thati Madhusudhan; Hongjie Wang; Beate K Straub; Elisabeth Gröne; Qianxing Zhou; Khurrum Shahzad; Sandra Müller-Krebs; Vedat Schwenger; Bruce Gerlitz; Brian W Grinnell; John H Griffin; Jochen Reiser; Hermann-Josef Gröne; Charles T Esmon; Peter P Nawroth; Berend Isermann
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

9.  Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies.

Authors:  Michelle Willicombe; Jill Moss; Linda Moran; Paul Brookes; Eva Santos-Nunez; Adam G McLean; Thomas Cairns; David Taube; Terence H Cook; Candice Roufosse
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

10.  Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).

Authors:  Fernando Souza-Fonseca-Guimaraes; Marianna Parlato; Rosane B de Oliveira; Douglas Golenbock; Katherine Fitzgerald; Irina N Shalova; Subhra K Biswas; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  J Biol Chem       Date:  2013-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.